Clinical Trial

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Study acronym: PROMs
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2024 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are: * To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients. * To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics. The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.
Trial Details
NCT Number NCT06662929
Lead Sponsor King Saud University
Conditions Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer, Nasopharyngeal Cancer, Oral Cancer, Tongue Cancer, Oral Neoplasm
Enrollment 125 participants
Start Date 2023-05-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-29